Arstat Pharmaceuticals Company

ARSTAT provides three transformational products for millions of women: NUVOCEPT - the first and only oral contraceptive designed for overweight and obese women (≈60% of 10 million US pill users), PREMRING - first-in-class vaginal ring for uterine fibroids and endometriosis (much-needed solution for >15 million US women), ENHANTA - first-in-class single non-hormonal therapy for painful and heavy menstrual periods (>25 million US women).
Industry: Reproductive Health & Contraception
Headquarters: Flemington, New Jersey, United States
Founded Date: 01-03-2021
Employees Number: 1-10

Visit Website
Register and Claim Ownership